Diabetes is a significant concern in the United States because of its high prevalence, morbidity, mortality, and medical costs. A key factor affecting hemoglobin A1c (HbA1c) control in diabetes is patient adherence to an appropriate plan of care, including prescribed medications. This paper presents patterns of HbA1c levels and diabetes medication adherence among people with type 2 diabetes mellitus based on real-world data from 2012 to 2014. It also presents the results of two correlation analyses between HbA1c levels and diabetes medication adherence and HbA1c levels and medical costs.
This report was commissioned by Intarcia Therapeutics, Inc.